128 related articles for article (PubMed ID: 9871514)
1. Novel HIV-protease inhibitors containing beta-hydroxyether and -thioether dipeptide isostere surrogates: modification of the P3 ligand.
Patel NM; Bennett F; Girijavallabhan VM; Dasmahapatra B; Butkiewicz N; Hart A
Bioorg Med Chem Lett; 1998 Apr; 8(8):931-4. PubMed ID: 9871514
[TBL] [Abstract][Full Text] [Related]
2. An efficient, stereoselective synthesis of the hydroxyethylene dipeptide isostere core for the HIV protease inhibitor A-792611.
Engstrom K; Henry R; Hollis LS; Kotecki B; Marsden I; Pu YM; Wagaw S; Wang W
J Org Chem; 2006 Jul; 71(14):5369-72. PubMed ID: 16808529
[TBL] [Abstract][Full Text] [Related]
3. Reduction of peptide character of HIV protease inhibitors that exhibit nanomolar potency against multidrug resistant HIV-1 strains.
Tamamura H; Koh Y; Ueda S; Sasaki Y; Yamasaki T; Aoki M; Maeda K; Watai Y; Arikuni H; Otaka A; Mitsuya H; Fujii N
J Med Chem; 2003 Apr; 46(9):1764-8. PubMed ID: 12699395
[TBL] [Abstract][Full Text] [Related]
4. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of a new hydroxyethylene dipeptide isostere Phe psi [CH2CH (OH)]Phe as HIV-1 protease inhibitor.
Chen HG; Sawyer TK; Wuts PG
Zhongguo Yao Li Xue Bao; 1994 Jan; 15(1):33-5. PubMed ID: 8010081
[TBL] [Abstract][Full Text] [Related]
6. Structure based design: novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors.
Ghosh AK; Krishnan K; Walters DE; Cho W; Cho H; Koo Y; Trevino J; Holland L; Buthod J
Bioorg Med Chem Lett; 1998 Apr; 8(8):979-82. PubMed ID: 9871524
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of HTLV-1 protease inhibitors containing hydroxyethylamine dipeptide isostere.
Akaji K; Teruya K; Aimoto S
J Org Chem; 2003 Jun; 68(12):4755-63. PubMed ID: 12790579
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of small-sized HIV protease inhibitors containing allophenylnorstatine.
Mimoto T; Kato R; Takaku H; Nojima S; Terashima K; Misawa S; Fukazawa T; Ueno T; Sato H; Shintani M; Kiso Y; Hayashi H
J Med Chem; 1999 May; 42(10):1789-802. PubMed ID: 10346931
[TBL] [Abstract][Full Text] [Related]
9. New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development.
Bold G; Fässler A; Capraro HG; Cozens R; Klimkait T; Lazdins J; Mestan J; Poncioni B; Rösel J; Stover D; Tintelnot-Blomley M; Acemoglu F; Beck W; Boss E; Eschbach M; Hürlimann T; Masso E; Roussel S; Ucci-Stoll K; Wyss D; Lang M
J Med Chem; 1998 Aug; 41(18):3387-401. PubMed ID: 9719591
[TBL] [Abstract][Full Text] [Related]
10. KNI-577, a potent small-sized HIV protease inhibitor based on the dipeptide containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
Kiso Y; Yamaguchi S; Matsumoto H; Mimoto T; Kato R; Nojima S; Takaku H; Fukazawa T; Kimura T; Akaji K
Arch Pharm (Weinheim); 1998 Mar; 331(3):87-9. PubMed ID: 9557134
[No Abstract] [Full Text] [Related]
11. Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands.
Chen X; Kempf DJ; Sham HL; Green BE; Molla A; Korneyeva M; Vasavanonda S; Wideburg NE; Saldivar A; Marsh KC; McDonald E; Norbeck DW
Bioorg Med Chem Lett; 1998 Dec; 8(24):3531-6. PubMed ID: 9934466
[TBL] [Abstract][Full Text] [Related]
12. Alpha-ketoamide Phe-Pro isostere as a new core structure for the inhibition of HIV protease.
Munoz B; Giam CZ; Wong CH
Bioorg Med Chem; 1994 Oct; 2(10):1085-90. PubMed ID: 7773625
[TBL] [Abstract][Full Text] [Related]
13. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel class of potent HIV-1 protease inhibitors containing the (R)-(hydroxyethyl)urea isostere.
Getman DP; DeCrescenzo GA; Heintz RM; Reed KL; Talley JJ; Bryant ML; Clare M; Houseman KA; Marr JJ; Mueller RA
J Med Chem; 1993 Jan; 36(2):288-91. PubMed ID: 8423599
[No Abstract] [Full Text] [Related]
15. Synthesis and structure-activity relationships of a series of penicillin-derived HIV proteinase inhibitors containing a stereochemically unique peptide isostere.
Holmes DS; Bethell RC; Cammack N; Clemens IR; Kitchin J; McMeekin P; Mo CL; Orr DC; Patel B; Paternoster IL
J Med Chem; 1993 Oct; 36(21):3129-36. PubMed ID: 8230099
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands.
Ghosh AK; Takayama J; Kassekert LA; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
Bioorg Med Chem Lett; 2015 Nov; 25(21):4903-4909. PubMed ID: 26096678
[TBL] [Abstract][Full Text] [Related]
17. Design of HIV protease inhibitors targeting protein backbone: an effective strategy for combating drug resistance.
Ghosh AK; Chapsal BD; Weber IT; Mitsuya H
Acc Chem Res; 2008 Jan; 41(1):78-86. PubMed ID: 17722874
[TBL] [Abstract][Full Text] [Related]
18. 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
Degoey DA; Grampovnik DJ; Flentge CA; Flosi WJ; Chen HJ; Yeung CM; Randolph JT; Klein LL; Dekhtyar T; Colletti L; Marsh KC; Stoll V; Mamo M; Morfitt DC; Nguyen B; Schmidt JM; Swanson SJ; Mo H; Kati WM; Molla A; Kempf DJ
J Med Chem; 2009 Apr; 52(8):2571-86. PubMed ID: 19323562
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological activity of potent HIV-1 protease inhibitors based on Phe-Pro dihydroxyethylene isosteres.
Benedetti F; Berti F; Budal S; Campaner P; Dinon F; Tossi A; Argirova R; Genova P; Atanassov V; Hinkov A
J Med Chem; 2012 Apr; 55(8):3900-10. PubMed ID: 22458611
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activity.
Young SD; Payne LS; Thompson WJ; Gaffin N; Lyle TA; Britcher SF; Graham SL; Schultz TH; Deana AA; Darke PL
J Med Chem; 1992 May; 35(10):1702-9. PubMed ID: 1588552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
